Company Encyclopedia
View More
name
Allist
688578.SH
Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.
3.184 T
688578.SHMarket value -Rank by Market Cap -/-

Financial Score

19/11/2025 Update
A
PharmaceuticalsIndustry
Industry Ranking1/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE34.90%A
    • Profit Margin41.68%A
    • Gross Margin97.89%A
  • Growth ScoreA
    • Revenue YoY48.49%A
    • Net Profit YoY52.90%B
    • Total Assets YoY33.61%A
    • Net Assets YoY33.64%A
  • Cash ScoreB
    • Cash Flow Margin239.95%C
    • OCF YoY48.49%A
  • Operating ScoreB
    • Turnover0.75B
  • Debt ScoreA
    • Gearing Ratio10.48%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More